Novartis charts next US investment with new radiopharma plant
As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for…
Novartis details plan for 2nd new US radiopharma plant
Novartis is wasting little time sketching out the radiopharmaceutical details of its $23 billion U.S. investment push. Shortly…